• High-complexity (CLIA) diagnostic testing
• Specialty and esoteric assays (highly specialized laboratory tests that are not routinely performed in standard clinical laboratories and typically require advanced expertise, unique methodologies, or specialized equipment).
Eurofins Clinical Diagnostics US delivers high-complexity (CLIA) diagnostic testing through a network of specialized laboratories including Eurofins Viracor, Eurofins Diatherix, and Eurofins DPT. These organizations provide a broad range of specialty and esoteric assays that require advanced methodologies and deep clinical expertise, supporting accurate diagnosis across complex disease states. From infectious disease and transplant monitoring to cardiovascular risk assessment and donor screening, these services enable clinicians with reliable, high-quality data to guide critical patient care decisions.
• Syndromic testing
• Real-time and quantitative PCR platforms
Eurofins Clinical Diagnostics US provides advanced molecular and PCR-based diagnostics through Eurofins Diatherix, Eurofins Viracor, and Eurofins DPT, enabling rapid and precise detection of infectious agents. These services include syndromic testing panels that identify multiple pathogens from a single sample, as well as real-time and quantitative PCR platforms that support sensitive and specific measurement of viral and bacterial loads. Together, these capabilities help clinicians accelerate diagnosis, monitor disease progression, and guide targeted treatment decisions.
• Syndromic testing
• Real-time and quantitative PCR platforms
Eurofins Genomics provides comprehensive genomic and sequencing services to support clinical and research applications. With capabilities in next-generation sequencing (NGS), Sanger sequencing, and custom genomic solutions, these services enable detailed analysis of genetic material to support disease research, biomarker discovery, and diagnostic development.
• Cell therapy–associated testing
• Highly specialized clinical assays
Eurofins CellTx provides specialized testing to support cell-based therapies and related clinical applications. With capabilities spanning donor screening and cell therapy–associated testing, these services ensure the safety, quality, and compliance of cellular products. Highly specialized assays support critical decision-making from donor qualification through development and delivery of transplantable cell-based therapies.
• Scalable laboratory operations
• Clinical trial, health system, and reference laboratory support
Eurofins Clinical Enterprise delivers scalable central laboratory and enterprise diagnostic solutions to support health systems, reference laboratories, and clinical trials. With integrated data management and standardized workflows, these services enable efficient, high-throughput testing and consistent results across large, complex programs. This approach supports operational efficiency while ensuring reliable data for clinical and research applications.
• Assay development → validation → commercialization
• Regulatory, logistics, and lifecycle support
Eurofins Clinical Enterprise and its broader ecosystem provide comprehensive support across the full diagnostic lifecycle, from assay development and validation to commercialization. These services integrate regulatory expertise, logistics, and operational support to help organizations bring new tests to market efficiently and maintain quality throughout the product lifecycle.